# Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

> **NCT00293280** · PHASE2 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 42 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** lomustine

## Key facts

- **NCT ID:** NCT00293280
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2007-07
- **Final completion:** —
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2013-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00293280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00293280, "Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00293280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*